Kalaris Therapeutics, Inc 10-K for FY2024
Kalaris Therapeutics, Inc. (KLRS)
10-K
2025-03-07
For: 2024-12-31
View Original
Added on
April 08, 2026
About this 10-K
Kalaris Therapeutics, Inc filed this 10-K on March 7, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $58.77M
- compared with a net loss of $190.42M a year earlier
- Diluted EPS
- -$11.73
- compared with -$42.09 a year earlier